24Sep

New AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC

As demand for rapid testing continues to accelerate at an unprecedented level, our response to assisting testing on a global scale must be in place to support accurate, reliable and easy-to-use testing. 

The AbC-19™ COVID-19 antibody test developed by Abingdon Health and the UK-RTC, achieves 98.03% sensitivity and 99.5% specifically, will play an invaluable role in overcoming unpredicted rapid testing outcomes.


Download the whitepaper to learn:

  • How the body responds to SARS-COV-2
  • The different approaches to antibody testing
  • The UK-RTC Abc-19 Rapid Test
  • The link between antibodies and immunity
  • The route towards therapies and immunisation 

Please access the complete whitepaper for this device here.

Related

Veravas and MIP Diagnostics Announce International Agreement for Improved Diagnostics

CHARLESTON, S.C. and OAKDALE, Minn., March, 13 2020, - Veravas, Inc., an emerging diagnostic company...

Read More >

OGT enhances customer experience with new Cytocell website

Oxford, UK – 7 March 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has launch...

Read More >

New Advanced Pipetting Academy Makes You a Pipetting Master

For many years Alpha Laboratories and Sartorius have delivered a popular training programme covering...

Read More >

QuantuMDx and Molbio announce Memorandum of Understanding (MoU)

QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understan...

Read More >

Quick, Reliable Endotoxin and β-glucan Testing

Take Control and Save Time with Easy In-house Testing

Read More >

EKF introduces accurate quantitative COVID-19 antibody test kit

New COVID-SeroKlir SARS-CoV-2 IgG antibody test kit is one of first to detect both the presence and ...

Read More >